Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer

Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by[18F]FDG-PET/CT

(2012) Juha T. Kauppi et al.   ACTA ONCOLOGICA

Volume-Based Parameters of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Improve Outcome Prediction in Early-Stage Non–Small Cell Lung Cancer After Surgical Resection

(2012) Seung Hyup Hyun et al.   ANNALS OF SURGERY

Radiomics: Extracting more information from medical images using advanced feature analysis

(2012) Philippe Lambin et al.   EUROPEAN JOURNAL OF CANCER

Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours

(2012) Christophe Van de Wiele et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response

(2012) M. Vanderhoek et al.   JOURNAL OF NUCLEAR MEDICINE

Are Pretreatment 18F-FDG PET Tumor Textural Features in Non-Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?

(2012) G. J. R. Cook et al.   JOURNAL OF NUCLEAR MEDICINE

Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy

(2012) Jonathan A. Abelson et al.   LUNG CANCER

Predicting outcomes in radiation oncology—multifactorial decision support systems

(2012) Philippe Lambin et al.   Nature Reviews Clinical Oncology

Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies

(2011) Floris H. P. van Velden et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prediction of residual metabolic activity after treatment in NSCLC patients

(2010) Emmanuel Rios Velazquez et al.   ACTA ONCOLOGICA

Strategies of assessing and quantifying radiation treatment metabolic tumor response using F18 FDG Positron Emission Tomography (PET)

(2010) Martin Fuss   ACTA ONCOLOGICA

Revisiting the prognostic value of preoperative 18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC)

(2009) Mohit Agarwal et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

(2009) R. L. Wahl et al.   JOURNAL OF NUCLEAR MEDICINE

Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan

(2009) Hugo J.W.L. Aerts et al.   RADIOTHERAPY AND ONCOLOGY

The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials

(2008) Ronald Boellaard et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prognostic Value of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients With Advanced-Stage Non–Small-Cell Lung Carcinoma

(2008) Jenny K. Hoang et al.   JOURNAL OF CLINICAL ONCOLOGY

Exploring feature-based approaches in PET images for predicting cancer treatment outcomes

(2008) I. El Naqa et al.   PATTERN RECOGNITION